REK7 is an Eph-related tyrosine kinase receptor expressed exclusively in the nervous system, predominantly in hippocampus and cortex. A soluble REK7-IgG fusion protein, produced to analyze the biological role of REK7, prevents axon bundling in cocultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. Using REK7-1gG as an affinity reagent, we purified and cloned a novel REK7 ligand called AL-1, a GPl-linked protein homologous to other members of an emerging ligand family. Membrane attachment of AL-1 appears necessary for receptor activation, since REK7 on cortical neurons is efficiently activated by transfected cells expressing GPl-linked AL-1, but not by soluble AL-1. Consistent with this, soluble AL-1 blocks axon bundling. Our findings, together with the observation that both molecules are expressed in the brain, suggest a role in the formation of neuronal pathways, a crucial feature of nervous system development and regeneration.
Introduction
Signaling by tyrosine kinase receptors has been well established as an important mechanism for regulating growth and differentiation of cells (reviewed by Schlessinger and UIIrich, 1992; UIIrich and Schlessinger, 1990) . Tyrosine kinase receptors are prevalent throughout the nervous system and are known to have a crucial role in both the development and maintenance of nerve cells (Snider, 1994) . Tyrosine kinase receptors can be classified into families based on their structural motifs (Fantl et al., 1993) . The largest of these is the Eph family (reviewed by Tuzi and Gullick, 1994) , comprising at least 13 distinct members. Many Eph family members are expressed exclusively or predominantly in the nervous system, suggesting they have specific functions there. The expression patterns that have been observed for some Eph family members suggest a role in embryogenesis (e.g., in pattern formation; Becker at al., 1994) . However, no specific biological functions have been elucidated for any member of this largest tyrosine kinase receptor family.
*These authors contributed equally to this work.
During a recent search to find new tyrosine kinase receptors and ligands that function in the nervous system, we isolated an Eph family receptor, REK7, that appears to be the rat homolog of CEK7 (Sajjadi and Pasquale, 1993) and is essentially identical to EHK-1 (Maisonpierre et al., 1993) and BSK (Zhou et al., 1994) . REK7 is expressed exclusively in the nervous system in both the embryo and adult. In the adult rat brain, the expression levels are highest in the hippocampus and cortex. (1. W. C., unpublished data; Maisonpierre et al., 1993; Zhou et al., 1994) . To probe the biological function of this receptor, we produced a REK7-IgG fusion protein and tested its effects in cocultures of primary cortical neurons plated on confluent cortical astrocytes, a cell culture system that promotes the formation of long axon bundles. In addition, we cloned a novel ligand for REK7, named AL-1. We furnish evidence suggesting that REK7 and AL-1 play a crucial role in axon fasciculation, thus providing an indication of a specific biological function for an Eph-related tyrosine kinase receptor.
Results and Discussion

REK7-1gG Blocks Axon Bundle Formation
We identified REK7 using a polymerase chain reaction (PCR)-based strategy (Raz et al., 1991) to screen for novel tyrosine kinase genes expressed in the hippocampus. A full-length cDNA encoding REK7 was subsequently isolated from a rat hippocarnpal cDNA library and encodes an Eph-related tyrosine kinase receptor that appears to be the rat homolog of CEK7 (Sajjadi and Pasquale, 1993) and that is essentially identical to EHK-1 (Maisonpierre et al., 1993) and BSK (Zhou et al., 1994) . Our rek7 cDNA corresponds to the splice variant of ehk-1 lacking the first of two tandem fibronectin type-Ill domains. Since in situ hybridization analysis revealed high levels of REK7 expression in neurons of the hippocampus and cortex (unpublished data; Maisonpierre et al., 1993; Zhou et al., 1994) , we tested the effect of blocking REK7 activity in cocultures of cortical neurons on astrocytes, using a soluble REK7-1gG fusion protein containing the extracellular domain of REK7. In these cultures, differentiation of neurons reaches an advanced stage analogous to late development in the brain, when neu ral pathways and fiber tracts are laid down. One manifestation of this is the formation of large axon bundles. These fiber bundles can be stained with an antibody against tau, a protein found in axons and, to a lesser extent, in dendrites (Binder et al., 1985) , but not with an antibody against microtubule-associated protein 2 (MAP2), a dendritic marker (Caceres et al., 1986; Dotti et al., 1987) (Figures 1A and 1C) . This indicates that the bundles are composed of axons. The addition of REK7-IgG to the culture medium completely prevented the formation of axon bundles, while having little or no effect on dendritic processes ( Figures 1B and 1D) . In contrast, a number of other receptor-lgG fusion proteins tested (e.g., CD4-1gG [Capon et al., 1989 ], TrkA-IgG [Shelton et al., and stained with anti-tau antibody, a marker for axons (A and B) or with anti-MAP2 antibody, a marker for dendrites (C and D) . To show that REK7-IgG does not inhibit axon outgrowth, cortical neurons were plated at low density on astrocytes (50,000 neurons per 35 mm well), to allow visualization of individual axons, and cultured for 4 days in the presence of either REK7-1gG (F) or a control protein, CD4-1gG (E). The cells were fixed and stained with an anti-neurofilament antibody that stains both axons and dendrites. Under these low density conditions, the cortical neurons do not form axon bundles, although they elaborate long axons, sim~ar to higher density cultures. 1995], and the Eph-related HTK-IgG [Bennett et al., 1994] ) had no effect on axon bundling (data not shown).
To determine whether the absence of axon bundles in REK7-1gG-treated cultures is due to an inhibition of the bundling process per se versus a generalized inhibition of axon outgrowth or reduction in neuron survival, we cultured cortical neurons at low density on astrocytes and measured the axon length per neuron. We observed no significant difference in either the density of processbearing cells or the length of individual axons in cultures treated with REK7-1gG versus a control protein, CD4-1gG (Figures 1E and 1F ; Table 1 ), indicating that REK7-1gG is not an inhibitor of axon outgrowth. Rather, these results suggest a role for REK7 in axon fasciculation, a crucial process during nervous system development and regeneration. In support of this notion, we stained the differentiated cocultures with antibodies against REK7 and a related Eph family receptor, SEK1 (Gilardi-Hebenstreit et al., 1992) . We detected expression of REK7, but not SEK1, on the surface of the axonal fibres within the bundles (Figure 2) . 
Purification of a Ligand for REK7
To isolate the putative REK7 ligand, we used REK7-1gG to screen cultured cell lines for cell surface expression of a REK7-binding activity. Analysis by flow cytometry identified the human breast carcinoma line, BT20 ( Figure 3A ), and HeLa (data not shown). Incubation of BT20 cells with phosphatidylinositol-specific phospholipase C (PIPLC) significantly reduced the relative cell fluorescence, a measure of the level of REK7-binding activity on the cell surface, from 571 to 128, suggesting that this ligand is linked with glycophosphatidylinositol (GPI; Figure 3A ). Competition binding of 1251-labeled REK7-1gG to BT20 cells and Scatchard analysis demonstrated a single high affinity binding interaction with a dissociation constant (KD) of 1 nM and a density of 8000 REK7-binding sites per cell. Knowing that many GPl-linked proteins undergo significant shedding from the cell surface (Metz et al., 1994) , we collected conditioned medium from BT20 cells and purified the REK7 ligand by affinity chromatography on a column of immobilized REK7-1gG. Analysis of the eluted fractions by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) revealed the presence of three proteins with Mr values of approximately 28,000, 27,000, and 25,000 (-28K, -27K, and -25K) that were absent in fractions eluted by similar treatment of a CD4-1gG precolumn (Figure 3B) . These proteins were electroblotted and subjected to N-terminal sequence analysis. The -2 7 K protein revealed the sequence NH2-DRYAVYWNSSNPRFQRGDYHIDVXlNDYXD. The -28K and -2 5 K proteins had blocked N-termini. Sequence analysis of peptides generated by in situ cyanogen bromide cleavage or in situ digestion with Lys-C endopeptidase (Wong et al., 1993; Henzel et al., 1990) revealed that the -28K, -27K, and -2 5 K proteins are related. A Lys-C endopeptide derived from the 28K protein had a sequence identical to the N-terminus of the -2 7 K protein, but containing 3 additional N-terminal residues, AVA. These data, together with the peptide map obtained from the Lys-C digestions, suggest that proteolytic processing of the -2 8 K protein at either the N-or C-terminus produces the -27K or -25K species, respectively. The following internal sequences were obtained for this ligand, named AL-I: M/KTIGVHDRVFDVNDKVEN-XLEPA, VNFDGYSAXDHTSKGFKRXEXNR, FQLFTPFS-LGXEXRXGREXFYISXAIP, and K/RWECNRP.
cDNA Cloning of the REK7 Ligand, AL-1 Based on the protein sequence determined for AL-1, we synthesized three degenerate oligonucleotide primer pools, which were used to amplify BT20 cell cDNA by PCR. Two fragments having the expected sizes (180 or 135 bp) were sequenced and predicted an amino acid sequence that matched that obtained by protein sequencing. The 180 bp fragment was used to screen a human fetal brain cDNA library (2 x 106 clones). Two positive clones, having inserts of 1.0 or 1.6 kb, respectively, were sequenced.
The AL-1 cDNA ( Figure 4A ) contains a presumed initiation codon at nucleotide position 323, within a consensus sequence favorable for eukaryotic translation initiation (Kozak, 1986) , followed by an open reading frame predicting a primary translation product of 228 amino acids. Figure 3. Identification of a Source for and Purification of a REK7 Ligand (A) Expression of a REK7-binding activity on the surface of BT20 cells and its release by PIPLC. BT20 cells were incubated for 2 hr at 4°C in DMEM medium without (top) or with (bottom) purified PIPLC (4 p.g/ ml). Cells were analyzed by indirect immunofluoreecence and flow cytometry after treatment with REK7-1gG (solid lines) or human IgG, Fc fragment (broken lines), followed by biotin-conjugated Fc fragmentspecific anti-human igG and phycoerythrin-conjugated streptavidin. (B) SDS-PAGE analysis of the purification of AL-1 by affinity chromatography. Lane 1, molecular size standards; lane 2, column load; lane 3, column flow-through; lane 4, first PBS wash; lane 5, second PBS wash; lane 6, first pH 3.0 wash; lane 7, second pH 3.0 wash; lane 8, third pH 3.0 wash (15 rain incubation). Lanes 9-11, CD4-1gG precolumn: lane 9, molecular size standards; lane 10, second pH 3.0 wash; lane 11, third pH 3.0 wash (15 min incubation). Gels were stained with silver. Note the specific elution of a major -28K band and minor -27K and -25K bands in lane 8.
Hydropathy analysis indicates that the first 18-20 amino acids are hydr~ophobic, presumably representing a signal peptide for secretion. Computer analysis (von Heijne, 1983) predicts the most favorable signal peptidase cleavage site to lie between residues 20 and 21, which would generate a mature polypeptide beginning with the sequence QDP. N-terminal glutamine residues are known to cyclize to form pyroglutamate (pyrrolidonecarboxylic acid), which would account for the blocked N-terminus of the -2 8 K species purified from BT20 cells. Digestion with pyroglupeptidase followed by N-terminal sequencing verifled that this is the case. The -27K species, which begins with the sequence DRY, thus lacks 9 N-terminal residues, consistent with the observed molecular mass difference of -1 kDa. The C-terminus of AL-1 contains a favorable sequence for G PI addition (Moran and Caras, 1991) , comprising a 15 residue C-terminal hydrophobic domain preceded by a potential cleavage/attachment site (Moran and Caras, 1994) for the anchor at Asn-103. This is consistent with our observation that AL-1 expressed on the surface of BT20 cells is GPI anchored, as is the ECK ligand, B61 (Bartley et al., 1994) .
Comparison of the AL-1 sequence with the GenBank sequence database indicates that AL-1 is a new member of an emerging ligand family ( Figure 4B ). ELF-1 (Cheng and Flanagan, 1994) , a ligand for the Eph-related receptors HEK and SEK, is the most closely related family member (showing 50.5% identity with AL-1), followed by B61 (showing 42.9% similarity). EHK1-L (Davis et al., 1994) , reportedly a ligand for EHK-1/REK7, is only 41.4% identical to AL-1. This raises the possibility that there may be more than one ligand for REK7, as is the case for the neurotrophin receptor TrkB, which binds both brainderived neurotrophic factor and neurotrophin-4/5 (Ip et al., 1993) . AL-1 shows lower homology (28.4%) with the extracellular domain of the transmembrane ligand, LERK2 (Beckmann et al., 1994) .
E x p r e s s i o n o f AL-1
Northern blot analysis revealed two AL-1 transcripts of -7 . 4 and 6 kb, expressed in brain, heart, placenta, lung, and kidney ( Figure 5A ). This is in contrast to the apparent lack of expression of rek7 in nonneural tissues (Maisonpierre et al., 1993 ; I. W. C., unpublished data). Within the brain, these same two transcripts were detectable in all regions examined ( Figure 5B ), indicating that, in contrast to the more restricted distribution of REK7, AL-1 is widely distributed throughout the brain.
To demonstrate AL-1 expression in our cortical neuronastrocyte cocultures and to determine where it is expressed, we analyzed RNA from both cortical neurons and astrocytes by reverse transcription-PCR (RT-PCR; Figure 5C) . A DNA fragment of the predicted size, hybridizing to an AL-1 probe, could be amplified using RNA from astrocytes or, to a lesser extent, from embryonic cortical neurons. Comparison of the amplified AL-1 fragment with that of a coamplified reference mRNA, glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Fort et al., 1985) , indicates that the level of AL-1 expression is significantly higher in astrocytes compared with neurons. In agreement with this, indirect immunofluorescent staining of the cocultures with REK7-1gG detected a punctate staining characteristic of GPI-anchored proteins on astrocyte cell membranes but not on neurons (Figure 6 ). Together, these data suggest that the bulk of the AL-1 expressed in this system is on astrocytes rather than on neurons.
A c t i v a t i o n o f R E K 7 b y A L -1
To determine whether AL-1 can activate as well as bind to REK7, we analyzed cultured primary cortical neurons by seen with other members of this ligand family (Davis et al., 1994) .
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Soluble AL-1 Is an Antagonist of Axon Bundling
Since soluble AL-1 binds to but does not efficiently activate REK7, we postulated that soluble AL-1 might act as an antagonist of RE K7 receptor activity and might block axon fasciculation in our cell culture system. This is indeed the case. The addition of soluble AL-1 to the culture medium of cortical neuron-astrecyte cocultures specifically prevented the formation of axon bundles, as does REK7-1gG ( Figure 7B ). Together with the observations that AL-1 is expressed in the cocultures (predominantly on astrocytes), that REK7 is expressed on both the axons fibers and cell bodies of the cortical neurons, and that AL-1 can activate REK7, this result further implicates AL-1 and REK7 as the molecules involved in axon bundling whose action is inhibited by REK7-1gG. However, there might also be other targets for REK7-1gG (e.g., EHK1-L) that we cannot at present rule out.
We also tested the effect on axon bundle formation of the anti-REK7 and anti-SEK antibodies, added to the culture medium at 200 t~g/ml. Neither reagent had any apparent effect on axon bundling in these cultures (data not shown). Since the anti-REK7 antibodies bind to the axon fibers but fail to block bundle formation, we conclude that mere binding to axons is not sufficient to interfere with the bundling process. This observation strengthens the argument that the inhibitory effects of REK7-1gG and soluble AL-1 are due to a specific inhibition of REK7 function.
Our findings are summarized in the schematic drawing shown in Figure 8 . Implicit in this model is the suggestion that the role of REK7 in axon fasciculation is probably indirect; i.e., our model suggests that REK7 and AL-1 do not themselves function as adhesion molecules but rather may be involved in regulating the fasciculation process. We speculate that activation of REK7 expressed on the neurons, by AL-1 expressed on the astrocytes, might activate a signaling pathway that promotes fasciculation, e.g., by up-regulating or activating adhesion molecules. This model is compatible with the current view that astrocytes play an important role during development of the CNS, where they are thought to provide a substratum and trophic support for growing axons (Hatten et al., 1990) . The idea that a tyrosine kinase is required for axon fasciculation is new and provocative. Neurons in the developing or regenerating nervous system presumably require two types of factors, those that promote growth and survival and those that provide spatial or directional guidance in the establishment of neuronal pathways (Tessier-Lavigne, 1994) . Tyrosine kinases are known to play a wellestablished role in the former but have not previously been shown to participate in the latter. Our findings, combined with the observation that both REK7 and AL-1 are expressed in the brain, suggest a role in the formation of neuronal pathways, a crucial feature of both development and regeneration in the nervous system.
Experimental Procedures Primary Cultures and Immunostaining
Astrocyte Cultures
Cerebral cortex from postnatal day 2 (P2) Wistar rat pups was dissociated, and the cells were grown in DMEM/F12 with 10o/o fetal bovine serum, 15 mM HEPES (pH 7,4). Confluent cultures were shaken at 37°C for 24 hr to obtain purified astrocytes (McCarthy and de Vellis, 1980) . Astrocyte cultures were trypsinized, replated, and grown to con fluency. Cocultures Cerebral cortex of embryonic day 16 (E16) rats was dissociated, and 4 x 105 cells were plated onto 35 mm dishes containing astrocytes that had been pretreated for 6 hr with or without protein A-purified REK7-1gG or control proteins (30 p,g/ml), or with soluble AL-1 (1-10 p.g/ ml). Cultures were grown for 4-7 days in a defined medium (Peterson et al., 1989) in the presence or absence of REK7-1gG and then fixed for 15 rain with 4o/0 paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.4). Fixed cultures were incubated with monoclonal antibodies against tau-1, MAP2 (both from Boehringer Manheim, Indianapolis, IN), or neurofilament (200 kDa; Chemicon, Temecula, CA). Bound antibody was visualized using the HRP-ABC method and the VIP substrate kit (Vector, Burlingame, CA).
Indirect Immunofluorescence
For detection of REK7, fixed cultures were treated with rabbit anti-REK7 IgG (20 p_g/ml), followed by fluorescein-conjugated goat antirabbit IgG (Cappel Laboratories). For detection of AL-1, fixed cultures were treated with REK7-1gG (10 p.g/ml), followed by biotin-conjugated Fc fragment-specific anti-human IgG and fluorescein-conjugated streptavidin (Jackson ImmunoResearch Laboratories, West Grove, PA).
Flow Cytometry
Cells were analyzed by indirect immunofluorescence and flow cytometry after treatment with REK7-1gG or human IgG, Fc fragment, followed by biotin-conjugated Fc fragment-specific anti-human IgG and phycoerythrin-conjugated streptavidin (Jackson ImmunoResearch). The fluorescence intensity was measured on a FACSCAN flow cytometer (Becton Dickinson Advanced Cellular Biology, San Jose, CA).
Protein Purification and Protein Sequence Determination
Conditioned medium from BT20 cells (12 liters) was concentrated 60-fold and loaded onto a 2 ml CD4-1gG-protein A agarose precolumn and a 1 ml REK7-1gG affinity column linked in tandem, at 4°C. The two columns were then separated, washed with 10 column volumes of PBS, and eluted with four washes of 100 mM sodium citrate (pH 3.0). The first two elutions were allowed to flow rapidly through the column, whereas the last two were left on the column for 15 rain before collection. The eluted fractions were neutralized to pH 7.4 with 50 mM potassium phosphate and analyzed by SDS-PAGE on 14% gels. The -25K-28K bands specifically eluted from the REK7 affinity column were separated by SDS-PAGE on a 4%-20% gel, electroblotted onto a Millipore PSQ membrane (Matsudaira, 1987) , and subjected to Edman protein sequence analysis (Henzel et al., 1987) .
PCR, cDNA Cloning, DNA Sequencing, and Northern Analysis
Based on the protein sequence obtained from AL-1 purified from BT20 cells, two degenerate PCR primer pools were synthesized: 5'-CCCTCGAGGTCGACGAT/CC/AGITAC/TGCIGT NG/C/-I-IAC/TT-GGAA and 5'-CCGCGGTGCGGCCGCTCTAGAGIATAICCG/ATCG/ AAAG/ATTC/T/A/GACCAT. Reverse-transcribed cDNA from BT20 cells was used as the template for PCR (Saiki et al., 1988) in a reaction volume of 50 p_l, containing 10 mM Tds (pH 8.3), 50 mM KCI, 1.5 mM MgCI2, 0.1% gelatin, 200 I~M dNTPs, 1 p.M of each primer pool, and 2.5 U of Taq polymerase. Initial template denaturation was at 80°C for 5 rain, followed by 30 cycles of 30 s at 94°C, 1 min at 55°C, and 1 rain at 72°C. The final cycle was allowed to extend for 10 rain at 72oC. An -186 bp product was obtained and subcloned into pBluescript KS(+), and two clones were sequenced. A 180 bp Sali-Xbal fragment was isolated from one of these clones and used to screen a human fetal brain cDNA library in Lambda ZAP (Stretagene, La Jolla, CA) under high stringency conditions. Plasmids containing the inserts of positive clones were recovered using the ZAP Express Vector Excision system (Stratagene) according to the manufacturer's instructions.
Two independent clones were sequenced on both strands by standard fluorescent dye terminator and dye primer methods on an ABI373 automated sequencer. The full-length cDNA was cloned into a mammalian expression vector containing the cytomegalovirus enhancer/ promoter and an SV40 polyadenylation sequence (Eaton et al., 1986) . Northern blots containing -2 p.g of poly(A) + RNA per lane were purchased from Clontech. The membranes were hybridized with the 1.6 kb AL-1 insert labeled with [~P]dCTP and [~P]dATP by random hexanucleotide priming (Feinberg and Vogelstein, 1983) , and the blots were washed at 65°C in 0.1 x SSC, 0.1o/o SDS. For the detection of AL-1 by RT-PCR, reactions were essentially as described above, but employing 35 cycles of 94°C for 1 min, 45°C for 1.5 rain, and 72 °C for 2 rain. A single 5' primer (5'-AGCAACCCCAG-ATTCCAGAGG) was used with one of two 3' primers (5:'I-I'CTACT-TTGTCGTTAACATCG or 5'-GAAAACACGATCATGAACACC).
Receptor Phosphorylation
HEK 293 cells were transfected with an AL-1 expression plasmid using the calcium phosphate coprecipitation method (Simonsen and Levinson, 1983) . Primary cortical neurons from E16 rats were plated at a density of 5 x 106 cells per 15 cm dish and cultured for 4 days. These cells were then treated with purified soluble AL-1 (0.1-1 p_g/ml) or 293 cells expressing membrane-bound AL-1 for 10 rain at 37°C. Immunoprecipitation with rabbit anti-REK7 and immunoblotting with mouse anti-phosphotyrosine were essentially as described (Kaplan et al., 1991a (Kaplan et al., , 1991b . Immunoblotted bands were visualized using a horseradish peroxidase-conjugated sheep anti-mouse antibody and the ECL fluorescence detection system (Amersham) as described by the manufacturer.
